Macasilang, James Eli C.
HRN: 24-99-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/14/2024
05/20/2024
IV
600mg
Q6hours
Acute Bacterial Infection, Unspecified
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes